fbpx
QQQ
+ 2.58
328.93
+ 0.78%
DIA
+ 2.29
343.25
+ 0.66%
SPY
+ 2.93
416.17
+ 0.7%
TLT
-0.69
140.61
-0.49%
GLD
+ 1.55
168.49
+ 0.91%

Why Is It Moving? Looking At United Natural Foods's Price Action Today

March 10, 2021 9:54 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

United Natural Foods's Stock Price And Volume Action

United Natural Foods (NYSE:UNFI) is currently up 14.03% to a price of $35.9. The stock's volume is currently 577.03 thousand, which is roughly 44.89% of its recent 30-day volume average of 1.29 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: United Natural Foods shares are trading higher after the company reported better-than-expected Q4 EPS results.

Insights On Recent Price Action

The stock's 50-day moving average was $24.42 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $32.96 and fallen to a low of $5.0.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

Stocks That Hit 52-Week Highs On Monday

    On Monday morning, 415 companies achieved new highs for the year. read more

Stocks That Hit 52-Week Highs On Thursday

  On Thursday morning, 420 companies hit new 52-week highs. read more

65 Biggest Movers From Yesterday

Gainers AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) shares jumped 89.1% to close at $15.28 on Wednesday as the company confirmed the FDA approval of FOTIVDA for relapsed, refractory advanced renal cell carcinoma. read more

44 Stocks Moving In Wednesday's Mid-Day Session

Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) climbed 85.3% to $5.43 in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech. It is a biopharmaceutical company focused on developing new molecules for oncology. read more